TP53和CDKN2A的变化定义了一个不良预后的亚组在患有结节T毛囊辅助细胞淋巴瘤的患者
Yuta Ito1,2, Joji Shimono3, Keisuke Kawamoto4,5
1Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
Leukemia
|May 2, 2025
概括
这项研究通过将病例分为分子子组来确定结节T毛囊辅助细胞淋巴瘤 (nTFHL) 的新型预后因素. 这些分类,特别是TP53/CDKN2A变化,显著影响患者的生存率和预后.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 节点T卵泡辅助细胞淋巴瘤 (nTFHL) 具有独特的特征,但其遗传变化的预后意义尚不清楚.
- 了解这些变化对于改善患者的结果和治疗策略至关重要.
研究的目的:
- 在nTFHL.中识别新的驱动基因和分子子组.
- 澄清体质变化的预后价值,并建立nTFHL的分子分类系统.
主要方法:
- 在173个nTFHL病例中分析了基因变异.
- 发现了36个驱动基因,其中包括4个新基因 (TET3,HLA-C,NRAS,KLF2).
- 根据主要驱动因素的改变,nTFHL分为四个分子子组的分类.
主要成果:
- 定义了四个分子子组:TR-I (+/-),AC53和NSD.
- AC53亚组的生存率最差,而NSD亚组的预后最好.
- TP53/CDKN2A变化和司机变化的存在独立地与更差的生存率有关.
结论:
- 分子分类对nTFHL具有临床意义,识别出不同的预后组.
- 确定了新的预后因素,包括TP53/CDKN2A变化.
- 开发了一种新的预后指数 (mTFHL-PI),用于将患者分为风险类别.
更多相关视频
07:39Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry
Published on: January 7, 2019
12.1K
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.2K
相关概念视频
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Inhibition of Cdk Activity
4.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.2K
M-Cdk Drives Transition Into Mitosis
5.4K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.4K
